• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病的胰岛素治疗:临床疗效、患者报告结局及依从性挑战的见解

Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.

作者信息

Emad-Eldin Mahmoud, Balata Gehan F, Elshorbagy Eman A, Hamed Mona S, Attia Mohamed S

机构信息

Department of Pharmacy Practice, Faculty of Pharmacy, Zagazig University, Zagazig HFQM+872, Al-Sharqia Governorate, Egypt.

Department of Pharmacy Practice, Faculty of Pharmacy, Heliopolis University, Cairo 44519, Egypt.

出版信息

World J Diabetes. 2024 May 15;15(5):828-852. doi: 10.4239/wjd.v15.i5.828.

DOI:10.4239/wjd.v15.i5.828
PMID:38766443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11099362/
Abstract

Insulin therapy plays a crucial role in the management of type 2 diabetes as the disease progresses. Over the past century, insulin formulations have undergone significant modifications and bioengineering, resulting in a diverse range of available insulin products. These products show distinct pharmacokinetic and pharmacodynamic profiles. Consequently, various insulin regimens have em-erged for the management of type 2 diabetes, including premixed formulations and combinations of basal and bolus insulins. The utilization of different insulin regimens yields disparate clinical outcomes, adverse events, and, notably, patient-reported outcomes (PROs). PROs provide valuable insights from the patient's perspective, serving as a valuable mine of information for enhancing healthcare and informing clinical decisions. Adherence to insulin therapy, a critical patient-reported outcome, significantly affects clinical outcomes and is influenced by multiple factors. This review provides insights into the clinical effectiveness of various insulin preparations, PROs, and factors impacting insulin therapy adherence, with the aim of enhancing healthcare practices and informing clinical decisions for individuals with type 2 diabetes.

摘要

随着2型糖尿病病情的发展,胰岛素治疗在其管理中起着至关重要的作用。在过去的一个世纪里,胰岛素制剂经历了重大的改良和生物工程改造,产生了各种各样的可用胰岛素产品。这些产品呈现出不同的药代动力学和药效学特征。因此,出现了各种用于管理2型糖尿病的胰岛素治疗方案,包括预混制剂以及基础胰岛素和餐时胰岛素的联合使用。不同胰岛素治疗方案的使用会产生不同的临床结果、不良事件,尤其是患者报告的结果(PROs)。PROs从患者的角度提供了有价值的见解,是改善医疗保健和为临床决策提供信息的宝贵信息来源。坚持胰岛素治疗是一项关键的患者报告结果,它会显著影响临床结果,并受多种因素影响。本综述深入探讨了各种胰岛素制剂的临床有效性、PROs以及影响胰岛素治疗依从性的因素,旨在改善医疗实践,并为2型糖尿病患者的临床决策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66a/11099362/0d9fa23c405e/WJD-15-828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66a/11099362/484379c2998b/WJD-15-828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66a/11099362/0d9fa23c405e/WJD-15-828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66a/11099362/484379c2998b/WJD-15-828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66a/11099362/0d9fa23c405e/WJD-15-828-g002.jpg

相似文献

1
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.2型糖尿病的胰岛素治疗:临床疗效、患者报告结局及依从性挑战的见解
World J Diabetes. 2024 May 15;15(5):828-852. doi: 10.4239/wjd.v15.i5.828.
2
Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.使用预混胰岛素类似物治疗2型糖尿病的实用方法
Clin Ther. 2005 Aug;27(8):1113-25. doi: 10.1016/j.clinthera.2005.07.003.
3
Premixed insulin treatment for type 2 diabetes: analogue or human?2型糖尿病的预混胰岛素治疗:类似物还是人胰岛素?
Diabetes Obes Metab. 2007 Sep;9(5):630-9. doi: 10.1111/j.1463-1326.2006.00654.x.
4
Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus.甘精胰岛素U100二十年:对其在2型糖尿病中疗效和安全性的系统评价
Diabetes Ther. 2022 Aug;13(8):1409-1481. doi: 10.1007/s13300-022-01284-2. Epub 2022 Jun 30.
5
6
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs.在美国口服抗糖尿病药物治疗失败的2型糖尿病患者中,起始甘精胰岛素治疗与预混胰岛素类似物治疗的真实世界结局。
Clinicoecon Outcomes Res. 2013 Oct 3;5:497-505. doi: 10.2147/CEOR.S49279. eCollection 2013.
7
Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?2型糖尿病胰岛素治疗的个体化强化——基础-餐时方案适合所有患者吗?
Curr Med Res Opin. 2016 Aug;32(8):1425-34. doi: 10.1080/03007995.2016.1181051. Epub 2016 May 25.
8
Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.胰岛素类似物和预混胰岛素类似物相对于人胰岛素的药代动力学和药效学优势:对疗效和安全性的影响。
Am J Med. 2008 Jun;121(6 Suppl):S9-S19. doi: 10.1016/j.amjmed.2008.03.022.
9
Rapid-acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes.速效胰岛素类似物:1型和2型糖尿病的理论与最佳临床实践
Diabetes Obes Metab. 2022 Jan;24 Suppl 1:63-74. doi: 10.1111/dom.14713. Epub 2022 Apr 25.
10
Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.采用 2 种方法评估德克萨斯州医疗补助计划 2 型糖尿病患者的基础胰岛素依从性。
J Manag Care Spec Pharm. 2020 Nov;26(11):1434-1444. doi: 10.18553/jmcp.2020.26.11.1434.

引用本文的文献

1
Inconvenience, lifestyle flexibility, glycemic control, and satisfaction with insulin treatment among patients with diabetes mellitus in palestine: a cross-sectional study.巴勒斯坦糖尿病患者的不便之处、生活方式灵活性、血糖控制及胰岛素治疗满意度:一项横断面研究
Sci Rep. 2025 Aug 21;15(1):30744. doi: 10.1038/s41598-025-15564-x.
2
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
3
Dynamic modeling of the Insulin-Glucose-Glucocorticoid impulsive control system.

本文引用的文献

1
Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis.一周一次胰岛素 IDC 与每日一次基础胰岛素的比较:一项荟萃分析。
Endocr Pract. 2024 Feb;30(2):128-134. doi: 10.1016/j.eprac.2023.11.004. Epub 2023 Nov 19.
2
Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes.2 型糖尿病患者起始基础胰岛素治疗后健康相关生活质量的变化。
Medicine (Baltimore). 2023 Aug 25;102(34):e34718. doi: 10.1097/MD.0000000000034718.
3
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
胰岛素-葡萄糖-糖皮质激素脉冲控制系统的动态建模
Sci Rep. 2024 Dec 28;14(1):31449. doi: 10.1038/s41598-024-83326-2.
糖尿病患者的患者报告结局:应该测量什么以及如何测量?一篇叙述性综述。
Diabetologia. 2023 Aug;66(8):1357-1377. doi: 10.1007/s00125-023-05926-3. Epub 2023 May 24.
4
Insulin injection practice and health related quality of life among individuals with diabetes at Tikur Anbessa Specialized Hospital, Ethiopia: a cross-sectional study.在埃塞俄比亚提克里安贝萨专科医院,对糖尿病患者的胰岛素注射实践和健康相关生活质量进行横断面研究。
Health Qual Life Outcomes. 2023 May 4;21(1):38. doi: 10.1186/s12955-023-02123-z.
5
The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance-2014-2018.2014 年至 2018 年间,具有联邦医疗保险优势计划的 1 型和 2 型糖尿病患者自付费用对胰岛素使用的影响。
Health Serv Res. 2024 Feb;59(1):e14152. doi: 10.1111/1475-6773.14152. Epub 2023 Mar 29.
6
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy.基于空腹血糖的基础-餐时胰岛素治疗起始日剂量估算公式。
Sci Rep. 2023 Jan 19;13(1):1032. doi: 10.1038/s41598-023-28138-6.
7
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.9. 血糖治疗的药物学方法:2023 年糖尿病的护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.
8
A Culturally Tailored Diabetes Self-Management Intervention Incorporating Race-Congruent Peer Support to Address Beliefs, Medication Adherence and Diabetes Control in African Americans: A Pilot Feasibility Study.一项针对非裔美国人的、融入种族一致的同伴支持以解决信念、药物依从性和糖尿病控制问题的文化定制糖尿病自我管理干预措施:一项试点可行性研究。
Patient Prefer Adherence. 2022 Oct 25;16:2893-2912. doi: 10.2147/PPA.S384974. eCollection 2022.
9
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 共识报告:2 型糖尿病患者高血糖管理。
Diabetes Care. 2022 Nov 1;45(11):2753-2786. doi: 10.2337/dci22-0034.
10
The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell.运动时 1 型糖尿病患者与非糖尿病患者的胰腺内分泌:超越β细胞。
Front Endocrinol (Lausanne). 2022 Sep 6;13:981723. doi: 10.3389/fendo.2022.981723. eCollection 2022.